CI
AZN icon

Cordant Inc’s AstraZeneca AZN Stock Holding History

Cordant Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424 Buy
+2
New +$376 ﹤0.01% 210

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Cordant Inc's AZN Position: Q2 2026 in Review

Cordant Inc opened a new position in AstraZeneca (AZN) in Q2 2026: 2 shares worth $424. The stake represents ﹤0.01% of the portfolio and ranks #210 among its holdings.

233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Cordant Inc held 2 shares of AstraZeneca worth $424 as of Q2 2026.
  • AstraZeneca was a new Cordant Inc position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #210 holding.
  • 233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.